Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced-Dose Versus Full-Dose Systemic Thrombolysis for High-Risk Pulmonary Embolism: A Multicentre, Randomised, Open-Label, Blinded-Endpoint Trial

NCT07816978 is registered in ClinicalTrials.gov with Sahlgrenska University Hospital as lead sponsor.

NCT NCT07816978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07816978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced-Dose Versus Full-Dose Systemic Thrombolysis for High-Risk Pulmonary Embolism: A Multicentre, Randomised, Open-Label, Blinded-Endpoint Trial
Lead sponsor
Sahlgrenska University Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
January 31, 2031
Enrollment
400 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism acute